COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead More About CSL Behring's Efforts with COVID-19
Advice for Aspiring Scientists
As college students return to campus, we asked CSL scientists to offer their best advice.
Explainer: What Is Rh Negative?
A treatment made from donated plasma helps Rh-negative moms have healthy babies.
Living With an Organ Transplant
The recipient’s physical health will be closely monitored. But don’t overlook the emotional impact.
The Promise of Big Data for Lung Disease Patients
The launch of an open-source repository of thousands of lung scans invites a new era of AI-assisted research into rare diseas…
CSL Launches Annual Scholarship Program
Thirty-seven students receive awards in the first year of a new program for employees and dependents.
Apprentices Training to Be Future Leaders
These four apprentices are learning and working in Bern, Switzerland. Hear what they have to say about the experience.
7th Annual Teen Impact Awards
The National Hemophilia Foundation honored 58 U.S. teens for speaking up, taking action and leading by example.
What's Next for Sickle Cell Disease?
A new supplement from the journal Nature explores the promise of potential treatments for the painful, debilitating condition…